During the past decade, Medisch Centrum Gorecht conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medisch Centrum Gorecht" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Familial Hypercholesterolemia" (2 trials), "Diabetes" (1 trials), "Symptomatic Atherosclerosis" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "Medisch Centrum Gorecht" in a lesser frequency.

Most popular intervention types in "Medisch Centrum Gorecht" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ALN-PCSSC" (1 trials), "Evolocumab" (1 trials), "Inclisiran" (1 trials) and "Normal Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medisch Centrum Gorecht" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Medisch Centrum Gorecht". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Medisch Centrum Gorecht, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medisch Centrum Gorecht, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".